Latest period
$33.92B
YoY change
-1.4%
5Y CAGR
+7.8%
Peak year (2021)
$30.69B
Latest annual
$29.70B
Total Debt history chart for AstraZeneca (AZN) from 1990 to 2025
Latest: $29.70B
Total Debt growth chart for AstraZeneca (AZN) from 1990 to 2025
Latest: -1.4%
Total Debt history table for AstraZeneca (AZN) from 1990 to 2025
| 2025 | $29.70B | -1.4% | −$411.00M | ||
| 2024 | $30.11B | +5.2% | +$1.49B | ||
| 2023 | $28.62B | -1.8% | −$521.00M | ||
| 2022 | $29.14B | -5.0% | −$1.54B | ||
| 2021 | $30.69B | +50.6% | +$10.31B | ||
| 2020 | $20.38B | +11.8% | +$2.15B | ||
| 2019 | $18.23B | -4.6% | −$886.00M | ||
| 2018 | $19.11B | +7.3% | +$1.31B | ||
| 2017 | $17.81B | +5.9% | +$999.00M | ||
| 2016 | $16.81B | +11.7% | +$1.75B | ||
| 2015 | $15.05B | +38.8% | +$4.21B | ||
| 2014 | $10.84B | +4.5% | +$467.00M | ||
| 2013 | $10.38B | +0.6% | +$66.00M | ||
| 2012 | $10.31B | +10.5% | +$982.00M | ||
| 2011 | $9.33B | -2.8% | −$267.00M | ||
| 2010 | $9.60B | -15.1% | −$1.71B | ||
| 2009 | $11.31B | -4.6% | −$541.00M | ||
| 2008 | $11.85B | -21.8% | −$3.31B | ||
| 2007 | $15.16B | +1139.2% | +$13.93B | ||
| 2006 | $1.22B | +1.8% | +$22.00M | ||
| 2005 | $1.20B | -5.4% | −$68.00M | ||
| 2004 | $1.27B | +178.9% | +$814.00M | ||
| 2003 | $455.00M | -46.1% | −$389.00M | ||
| 2002 | $844.00M | -38.3% | −$524.81M | ||
| 2001 | $1.37B | +61.9% | +$523.43M | ||
| 2000 | $845.38M | -24.4% | −$273.07M | ||
| 1999 | $1.12B | +7.3% | +$76.04M | ||
| 1998 | $1.04B | -11.1% | −$129.65M | ||
| 1997 | $1.17B | -5.7% | −$71.22M | ||
| 1996 | $1.24B | -2.0% | −$25.34M | ||
| 1995 | $1.27B | +8.5% | +$99.19M | ||
| 1994 | $1.17B | -36.6% | −$673.66M | ||
| 1993 | $1.84B | -46.8% | −$1.62B | ||
| 1992 | $3.47B | +1.2% | +$41.01M | ||
| 1991 | $3.43B | -1.5% | −$51.73M | ||
| 1990 | $3.48B | — | — |
- 2025$29.70B-1.4%
- 2024$30.11B+5.2%
- 2023$28.62B-1.8%
- 2022$29.14B-5.0%
- 2021$30.69B+50.6%
- 2020$20.38B+11.8%
- 2019$18.23B-4.6%
- 2018$19.11B+7.3%
- 2017$17.81B+5.9%
- 2016$16.81B+11.7%
- 2015$15.05B+38.8%
- 2014$10.84B+4.5%
- 2013$10.38B+0.6%
- 2012$10.31B+10.5%
- 2011$9.33B-2.8%
- 2010$9.60B-15.1%
- 2009$11.31B-4.6%
- 2008$11.85B-21.8%
- 2007$15.16B+1139.2%
- 2006$1.22B+1.8%
- 2005$1.20B-5.4%
- 2004$1.27B+178.9%
- 2003$455.00M-46.1%
- 2002$844.00M-38.3%
- 2001$1.37B+61.9%
- 2000$845.38M-24.4%
- 1999$1.12B+7.3%
- 1998$1.04B-11.1%
- 1997$1.17B-5.7%
- 1996$1.24B-2.0%
- 1995$1.27B+8.5%
- 1994$1.17B-36.6%
- 1993$1.84B-46.8%
- 1992$3.47B+1.2%
- 1991$3.43B-1.5%
- 1990$3.48B—
Total Debt values are taken from AstraZeneca's reported balance sheets (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported total debt is $33.92B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, AstraZeneca (AZN) total debt totalled $29.70B – edged down 1.4% year-over-year.
Across 2020–2025 (5 years), AstraZeneca total debt produced a CAGR of +7.8% – with mixed annual results across the window.
2021 marks the peak total debt at $30.69B, with the historical low of $455.00M recorded in 2003.
AstraZeneca Total Debt by Year
AstraZeneca Total Debt 2025: $29.70B
AstraZeneca posted total debt of $29.70B in 2025, edged down 1.4% below 2024.
AstraZeneca Total Debt 2024: $30.11B
In 2024, AstraZeneca reported total debt of $30.11B, grew 5.2% from 2023.
AstraZeneca Total Debt 2023: $28.62B
AstraZeneca total debt in 2023 was $28.62B, edged down 1.8% below 2022.
AstraZeneca Total Debt 2022: $29.14B
2022's total debt for AstraZeneca came in at $29.14B, declined 5.0% below 2021.
AstraZeneca Total Debt 2021: $30.69B
AstraZeneca total debt in 2021 was $30.69B.
See more financial history for AstraZeneca (AZN).
Sector peers by Total Debt
Healthcare peers of AstraZeneca (AZN), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $40.85B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $20.59B
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation